Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia

Clinical trial NCT06953869 · RECRUITING

Trial details

NCT number: NCT06953869
Sponsor: Vanda Pharmaceuticals
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Insomnia Disorder

Start date: 2025-04-21
Primary completion: 2027-11-01
Enrollment: 420

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.